ENaC hyperactivity is also seen in cystic fibrosis patients as a result of its dysregulation caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) protein (Kunzelmann et al., 2001). Here, CFTR is linked to cystic fibrosis.